Poll Results: Dual or Triple Antiplatelet Therapy With Stents After PCI
In our most recent poll, we surveyed the duration of aspirin after percutaneous coronary intervention (PCI) in patients with atrial fibrillation. The majority (59%) responded that they would continue aspirin for 1 month. Relatively equal numbers indicated they would continue aspirin until the time of discharge (12%), for 1 week after PCI (14%), or would not continue aspirin after PCI (15%). Current American College of Cardiology and American Heart Association guidelines recommend dual antiplatelet therapy (DAPT) with clopidogrel preferred over other antiplatelet agents. A transition to double at 4-6 weeks may be considered. In contrast, the updated European Society of Cardiology guidelines recommend DAPT with clopidogrel as the default strategy for up to 12 months after a short period up to 1 week of aspirin. Aspirin could be prolonged up to 1 month when the ischemic risk outweighs the bleeding risk.
Keywords: Acute Coronary Syndrome, Platelet Aggregation Inhibitors, Aspirin, Percutaneous Coronary Intervention, American Heart Association, Atrial Fibrillation, Patient Discharge
< Back to Listings